Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Longpre Lara, Directeur du Développement. Director active across 1 company, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 13 disclosures have been recorded. Breakdown: 1 buy · 3 sells. Total volume traded: €79k. History available since 10 May 2021. The latest transaction was filed on 10 September 2019 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Longpre Lara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1,259 shares@ US$14.6210.6% of flowCommon StockSEC:0001209191-21-032154:0
13 of 13 declarations
About Longpre Lara
Lara Longpre is the Chief Development Officer at Mirum Pharmaceuticals, Inc. She is responsible for business development strategy and expanding the company's operations. Her expertise in the pharmaceutical sector is a major asset for the organization's growth.